Immune Infertility Diagnostic Study: Inclusion & Exclusion Criteria

This article provides general inclusion and exclusion criteria for a clinical diagnostic study focusing on patients with immune infertility. It is important to understand that these criteria are suggestions and should be tailored to the specific objectives and population of your study. Consulting with a medical expert or reproductive specialist is highly recommended to ensure the appropriate criteria are used.

Inclusion criteria:

1. Male or female patients aged between 18 and 45 years.
2. Patients with a documented history of infertility or difficulty in conceiving for at least one year.
3. Patients with a confirmed diagnosis of immune infertility, including conditions such as antisperm antibodies or other immune-related factors affecting fertility.
4. Patients willing to provide informed consent and participate in the study.
5. Patients who are willing to comply with the study requirements, including attending all study visits and follow-up appointments.
6. Patients who have not received any immunosuppressive therapy within the last six months.
7. Patients who are not currently undergoing any fertility treatment, such as in vitro fertilization (IVF) or intrauterine insemination (IUI).

Exclusion criteria:

1. Patients with a known history of genetic abnormalities or chromosomal disorders associated with infertility.
2. Patients with a history of major systemic diseases, such as cancer, autoimmune disorders, or endocrine disorders that may affect fertility.
3. Patients with active infections, including sexually transmitted infections, which can interfere with fertility or compromise the study results.
4. Patients with a history of pelvic inflammatory disease (PID) or any other condition affecting the reproductive organs.
5. Patients with a history of recurrent miscarriages or multiple failed IVF cycles.
6. Patients with a known allergy or hypersensitivity to any medications or substances used in the study.
7. Pregnant or lactating individuals, as pregnancy can affect immune responses and fertility outcomes.
8. Patients who are unable to comply with the study requirements or follow the study protocol.